Voluntary Product Recall &
Third-Party Lab Reporting Error

“At Blue Collar Criminals, our ongoing commitment to safety, quality, and transparency is non-negotiable. Safe, affordable cannabis products are standard practice for our team, and we hold our operations and our partners to the highest regulatory expectations.”

— Executive Leadership, Blue Collar Criminals

01

Scope of Recall & Batch Clarification

Recall Status:BIS091326-1 — Voluntarily RecalledSMG091326 — Voluntarily RecalledBIS091326-2 — Restricted Tag Scope

Batch Number	Strain	Recall Status	Operational Details & Tag Scope
BIS091326-1	Biscotti	Voluntarily Recalled	Impacted by lab error; fully quarantined across retail locations.
SMG091326	S’mores Gelato	Voluntarily Recalled	Impacted by lab error; fully quarantined across retail locations.
BIS091326-2	Biscotti	Restricted Tag Scope	Holds valid passing test. Recall applies ONLY to tags that never left facility: 1A40E0100002A37000008213 1A40E0100002A37000008217 1A40E0100002A37000008235 1A40E0100002A37000008250

02

Timeline of Events

1. Sept 14, 2026: Samples submitted to Steep Hill Oklahoma (LAAA-NJT2-DMOG) for mandatory compliance testing.
2. Sept 22, 2026: Received official passing test documentation for both batches.
3. Sept 23–28, 2026: Delivered 7 orders across 7 dispensary locations (~50 total units sold to patients).
4. Sept 29, 2026: Internal compliance team discovered batch statuses changed to non-passing in state system without lab notification.
5. Action Taken: Notified OMMA and immediately executed a full voluntary recall/quarantine across all 7 dispensaries.

03

Regulatory Safeguards & Operational Next Steps

Systemic Transfer Safeguards

State law strictly prohibits transfers without verified passing tests in the seed-to-sale system. Initial distribution occurred solely because the third-party lab uploaded passing results.

Quality Assurance Commitment

We are re-evaluating third-party testing partnerships and establishing heightened external verification workflows to ensure lab errors never affect patients or dispensary partners.

Executive Inquiries

PJ James

(405) 417-5333